Navigation Links
Nile Therapeutics Reports 2009 Second Quarter Financial Results
Date:8/13/2009

announce interim results of the study later this year, with results from the full study available in 2010.

About Nile Therapeutics

Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical needs. Nile is initially focusing its efforts on developing its lead compound, CD-NP, a novel rationally designed chimeric peptide in clinical studies for the treatment of heart failure, and CU-NP, a novel rationally designed natriuretic peptide. A key component of the company's strategy is to acquire the global rights to additional compounds to expand its portfolio. More information on Nile can be found athttp://www.nilethera.com.

Safe Harbor Paragraph for Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding the timing, progress and anticipated results of the clinical development, regulatory processes, clinical trial timelines, anticipated benefits of CD-NP, Nile's strategy, future operations, outlook, milestones, the timing and success of Nile's product development, future financial position, future financial results, plans and objectives of management are forward-looking statements. Nile may not actually achieve these plans, intentions or expectations and Nile cautions investors not to place undue reliance on Nile's forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements Nile makes. Various important factors that co
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Epix Pharmaceuticals, Inc. Announces PRX-07034 Therapeutics - CNS Phase 2 Will be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
2. Plasma Protein Therapeutics Association Urges CMS For Appropriate Hospital Outpatient Drug Reimbursement
3. Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record
4. Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results
5. Rx for Africa, Inc. and Zirus, Inc. Create Joint Venture, ZiRx Therapeutics, Ltd.
6. Transition Therapeutics to Present at Canaccord Adams 29th Annual Global Growth Conference
7. Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
8. Cell Therapeutics, Inc. (CTI) to Report Second Quarter Financial Results on August 6
9. Quark Pharmaceuticals to Participate in IBCs Oligonucleotide Therapeutics: From Concept to Implementation Conference
10. United Therapeutics Corporation Reports Second Quarter 2009 Financial Results
11. Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... to a gynaecologist or midwife are generally associated ... could offer so much more. Women, doctors and ... opportunities for dialogue about sexual health, reveals a ... of Gothenburg, Sweden. , Many young women see ... 500 women aged 23-29 answered questions about their ...
(Date:12/15/2009)... Scientists seeking to understand how to make an AIDS ... It turns out that the immune system can indeed ... antibodies but at the same time, the immune ... are eliminated before they have a chance to mature. ... antibody against a viral disease is under the control ...
(Date:12/15/2009)... Agency has requested documents from an investigative journalist, even though ... under the Freedom of Information Act. , ... ... bizarre about-face, the secretive Central Intelligence Agency has requested documents ... obtained them from the CIA itself under the Freedom of ...
(Date:12/15/2009)... safer than wood fiber , , TUESDAY, Dec. 15 (HealthDay News) ... in a fall are much lower on playgrounds with granite ... research has found. , Researchers at the Hospital for Sick ... surfaces of either granite sand or engineered wood fiber. Their ... . , The risk of a broken arm resulting from ...
(Date:12/15/2009)... – Seattle, WA) – Delicious Planet, Seattle’s premier organic meal ... the launch of its Delicious Planet Detox Program, Randi Carter, ... ... (December 15, 2009 – Seattle, WA) – ... ) is accepting orders now for the launch of its ...
Breaking Medicine News(10 mins):Health News:More about sex and relationships needed at gynecological visits 2Health News:Biological catch-22 prevents induction of antibodies that block HIV 2Health News:CIA Requests its Own Documents from Author 2Health News:CIA Requests its Own Documents from Author 3Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 2Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 3Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 4
... brains of people who are victims of tone-deafness do not ... the current issue of Brain, was conducted by a ... Neurological Institute and the Newcastle University Medical School. Tone ... which impedes normal functioning people to learn even fundamental music ...
... 523 children and adolescents in the United States had ... a major national study called SEARCH for Diabetes in ... diabetes among youth under the age of 20 ever ... Ph.D., M.S., associate professor of epidemiology and prevention at ...
... Osteoarthritis, the degenerative inflammatory bone disease, may be a sign ... print in the Annals of the Rheumatic Diseases. ,The ... people, aged between 30 and 79. Most of them were ... of all participants to check for signs of osteoarthritis and ...
... promise as an anti-cancer agent, inhibiting a gene found ... to researchers at the University of Illinois at Chicago ... Oct. 1 issue of Cancer Research. ,"We ... in cancer cells to screen for promising anti-cancer agents," ...
... sonography shows liver and spleen injuries better than ... // at the University of California, Davis School ... ,This study included 22 liver, spleen ... of the 22 injuries while non-contrast-enhanced sonography revealed ...
... rebuild after years of dictatorship and war, Iraqi craniofacial ... in treating many of the most serious injuries caused ... step forward was last year's "Kuwait Plast 2005" meeting, ... American counterparts in a 5-day exchange of surgical knowledge ...
Other Medicine News:Health News:Understanding Reasons for Tone deafness 2Health News:One in 523 Children and Adolescents Have Diabetes 2Health News:One in 523 Children and Adolescents Have Diabetes 3Health News:Osteoarthritis May be Sign of Faster “Biological Ageing 2Health News:Antibiotic Inhibits Cancer Gene Activity 2Health News:Journal of Craniofacial Surgery Publishes Research by Iraqi Surgeons 2
(Date:12/15/2009)... CLEVELAND, Dec. 15 At today,s regular meeting ... (NYSE: LZ ), the board declared a ... March 10, 2010 to holders of record at the ... About The Lubrizol Corporation ,, The Lubrizol Corporation ... chemical company that produces and supplies technologies that improve ...
(Date:12/15/2009)... -- Ghent University Hospital in Belgium, among the ... treatments using arc therapy, has carried out its ... technology from Varian Medical Systems ( VAR). A ... just 75 seconds, over four times faster than ... would have taken more than five minutes using ...
(Date:12/15/2009)... Vivakor, Inc. (OTC Bulletin Board: ... reported strong performance in 2009. Vivakor is ... with divisional spokes developing multiple products and ... strategy is anchored to the concept of ... Vivakor,s R&D efforts target commercialization and product-specific ...
Breaking Medicine Technology:Lubrizol Declares Dividend 2European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient 2European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient 3Vivakor Divisions Continue to Demonstrate Independent Growth 2Verizon Wireless Offers Home Health Care Industry Custom Mobile Application To Be More Productive 5289 1Verizon Wireless Offers Home Health Care Industry Custom Mobile Application To Be More Productive 5289 2Odyssey Thera Announces Achievement of Pfizer Drug Candidate Milestones 5287 1Panasonic Offers U are U 28R 29 Fingerprint Sensor From DigitalPersona on Stingray JS 950 Point of Sale Workstations 10286 1Panasonic Offers U are U 28R 29 Fingerprint Sensor From DigitalPersona on Stingray JS 950 Point of Sale Workstations 10286 2
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Quatroloc Revision Hip System...
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The Precedent establishes a new generation of revision hip stems....
Medicine Products: